These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24295642)

  • 1. Drug enterohepatic circulation and disposition: constituents of systems pharmacokinetics.
    Gao Y; Shao J; Jiang Z; Chen J; Gu S; Yu S; Zheng K; Jia L
    Drug Discov Today; 2014 Mar; 19(3):326-40. PubMed ID: 24295642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model systems for pharmacokinetics of steroid drugs subject to enterohepatic circulation.
    Schumann W; Hillesheim HG; Gira G
    Exp Clin Endocrinol; 1986 Jul; 87(2):118-24. PubMed ID: 3758191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A reversible clearance model for the enterohepatic circulation of drug and conjugate metabolite pair.
    Semmes RL; Shen DD
    Drug Metab Dispos; 1990; 18(1):80-7. PubMed ID: 1970782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of human pharmacokinetics-biliary and intestinal clearance and enterohepatic circulation.
    Fagerholm U
    J Pharm Pharmacol; 2008 May; 60(5):535-42. PubMed ID: 18416932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of intestinal absorption into the portal system in enterohepatic circulation by measuring the difference in portal-venous blood concentrations of diclofenac.
    Tabata K; Yamaoka K; Fukuyama T; Nakagawa T
    Pharm Res; 1995 Jun; 12(6):880-3. PubMed ID: 7667194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enterohepatic circulation of lorazepam and acetaminophen conjugates in ponies.
    Greenblatt DJ; Engelking LR
    J Pharmacol Exp Ther; 1988 Feb; 244(2):674-9. PubMed ID: 3346841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of enterohepatic recirculation in drug disposition: cooperation and complications.
    Malik MY; Jaiswal S; Sharma A; Shukla M; Lal J
    Drug Metab Rev; 2016 May; 48(2):281-327. PubMed ID: 26987379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymptotics and bioavailability in a 17-compartment pharmacokinetic model with enterohepatic circulation and remetabolization.
    Horkovics-Kovats S; Zlatos P
    Math Biosci; 2006 Sep; 203(1):19-36. PubMed ID: 16616213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the enterohepatic recirculation of Adriamycin and its metabolites by a linked-rat model.
    Behnia K; Boroujerdi M
    Cancer Chemother Pharmacol; 1998; 41(5):370-6. PubMed ID: 9523732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency of enterohepatic circulation, its determination and influence on drug bioavailability.
    Horkovics-Kovats S
    Arzneimittelforschung; 1999 Oct; 49(10):805-15. PubMed ID: 10554656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption and enterohepatic circulation of baicalin in rats.
    Xing J; Chen X; Zhong D
    Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new analysis method for disposition kinetics of enterohepatic circulation of diclofenac in rats.
    Fukuyama T; Yamaoka K; Ohata Y; Nakagawa T
    Drug Metab Dispos; 1994; 22(3):479-85. PubMed ID: 8070327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference.
    Moriwaki T; Yasui H; Yamamoto A
    J Pharmacokinet Pharmacodyn; 2003 Apr; 30(2):119-44. PubMed ID: 12942684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterohepatic circulation of clioquinol in the rat.
    Kotaki H; Yamamura Y; Tanimura Y; Saitoh Y; Nakagawa F; Tamura Z
    J Pharmacobiodyn; 1984 Jun; 7(6):420-5. PubMed ID: 6237189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General treatment of the enterohepatic recirculation of drugs and its influence on the area under the plasma level curves, bioavailability, and clearance.
    Peris-Ribera JE; Torres-Molina F; Garcia-Carbonell MC; Aristorena JC; Granero L
    Pharm Res; 1992 Oct; 9(10):1306-13. PubMed ID: 1448431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats.
    Huntjens DR; Strougo A; Chain A; Metcalf A; Summerfield S; Spalding DJ; Danhof M; Della Pasqua O
    Br J Pharmacol; 2008 Mar; 153(5):1072-84. PubMed ID: 18193075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local absorption kinetics into the portal system using the portal-venous concentration difference after an oral dose of diclofenac in the awakening rat. Accelerative effect of bile on intestinal absorption of diclofenac.
    Tabata K; Yamaoka K; Fukuyama T; Nakagawa T
    Drug Metab Dispos; 1996 Feb; 24(2):216-20. PubMed ID: 8742234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An equation for the systemic availability of drugs undergoing simultaneous enterohepatic cycling, first-pass metabolism, and intestinal elimination.
    Shepard TA; Reuning RH
    Pharm Res; 1987 Jun; 4(3):195-9. PubMed ID: 3509282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Mice: Potential Enterohepatic Circulation and Target-Mediated Disposition.
    Guan X; Morris ME
    Pharm Res; 2019 Dec; 37(1):5. PubMed ID: 31823112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of intestinal availability of various drugs in the oral absorption process using portal vein-cannulated rats.
    Matsuda Y; Konno Y; Satsukawa M; Kobayashi T; Takimoto Y; Morisaki K; Yamashita S
    Drug Metab Dispos; 2012 Dec; 40(12):2231-8. PubMed ID: 22930277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.